Biomarker: PIVKA-II (Protein Induced Vitamin K Absence or Antagonist-II)

A biomarker of liver cells for the management of hepatocellular carcinoma (HCC)

PIKVA-II is an immature form of prothrombin also known as DCP (Des-gamma-Carboxy Prothrombin), vitamin Kcoagulation factor, synthesized in the liver. In absence of vitamin K or when its action is antagonized (warfarin), PIVKA-II is released into the blood.

Phenotypic changes of liver cells enhance the production of PIVKA-II via impairments of vitamin K uptake1. PIVKA-II is an established HCC marker.

PIVKA-II serum and tissue overexpression are related to worse tumor behavior2-3, such as the presence of (micro) vascular invasion and intrahepatic metastasis of HCC cells and may indicate a poor prognostic outcome.


Lumipulse® G PIVKA-II

PIVKA-II is a biomarker of liver cells for the management of hepatocellular carcinoma (HCC). Our Lumipulse G immunoreaction cartridges are for in vitro diagnostic (IVD) use with the LUMIPULSE G system for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum.

Read more here

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.